News

WHO is alerting health-care professionals and regulatory authorities to the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with the use of semaglutide medicines—Ozempic, ...
As the NHS rolls out Mounjaro being prescribed by GPs, weight loss jabs have been linked to potentially fatal side effects in new data ...
A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.
I'm in London, and I just paid for this damn fat drug I take. I said, it's not working. They said, he said, I just paid $88 ...
GLP-1RA use necessitated shifting priorities in nutrition and lifestyle modification among patients with obesity, according ...
The United Kingdom's health regulator is investigating weight loss jabs like Ozempic and Mounjaro after linking it to ...
Altimmune, Inc.'s pemvidutide shows promising results in MASH resolution and weight loss, paving the way for phase 3 trials.
Eli Lilly will soon launch Mounjaro KwikPen in India. This follows regulatory approval for the diabetes and obesity drug. The ...
Hundreds of people have reported health complications linked to the use of popular weight loss jabs. The users of the jabs ...